Purity
99%+
Concentration
50mg
Molecular Weight
1479.5 g/mol
CAS Number
137525-51-0
Research Profile
Mechanism of Action
- —Stimulates glucose-dependent insulin release via receptor activation pathways
- —Reduces glucagon secretion through dual peptide engagement mechanisms
- —Initiates metabolic substrate utilization through downstream signaling
Drug Content
Clinical Parameters
ReceptorPeptide / Synthetic
SubcutaneousInjectable
Human Trials8 Days
Laboratory Standards
The Precision of Synthesis
Our Radiance is synthesized via solid-phase methodology, ensuring the highest degree of structural integrity. Every sequence is scrutinized against theoretical models to guarantee exact molecular match.
Each batch undergoes a full HPLC purity analysis and mass spectrometry confirmation before release.
Complementary Sequences
Recommended for targeted decreases in protocols.
CGMP Compliant
Exclusive Service
CLIA Qualified
Clinical Precision